| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/27/1995 | WO1995019780A1 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity |
| 07/27/1995 | WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/27/1995 | WO1995019770A1 Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
| 07/27/1995 | WO1995019767A1 Guanylhydrazones for treating inflammatory conditions |
| 07/27/1995 | CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/27/1995 | CA2181431A1 Haemopoietic maturation factor |
| 07/27/1995 | CA2181358A1 Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex |
| 07/27/1995 | CA2181254A1 Particulate material |
| 07/27/1995 | CA2180834A1 Antibodies to egf receptor and their antitumour effect |
| 07/27/1995 | CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/27/1995 | CA2158760A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 07/27/1995 | CA2126361A1 Gene encoding cationic amino acid transporter protein |
| 07/26/1995 | EP0664287A1 Vitamin D Compounds and method of preparing these compounds |
| 07/26/1995 | EP0664122A1 Inhibition of imperfect tissue repair |
| 07/26/1995 | EP0664120A1 Device for the vaginal administration of tamoxifen and its analogs |
| 07/26/1995 | EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 07/26/1995 | EP0663914A1 Process for the preparation of 9-amino camptothecin |
| 07/26/1995 | EP0663909A1 Method of obtaining 10-deacetylbaccatine iii. |
| 07/26/1995 | EP0663907A1 Method of preparing taxane derivatives. |
| 07/26/1995 | EP0663906A1 Method of preparing taxane derivatives. |
| 07/26/1995 | EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
| 07/26/1995 | EP0663900A1 Metal-oxime chelates for use as radiopharmaceutical agents |
| 07/26/1995 | EP0663832A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis |
| 07/26/1995 | CN1105585A Preparation and technology of active anticancer Chinese herbal medicine |
| 07/25/1995 | US5436401 Skin disorders |
| 07/25/1995 | US5436400 Isolation and structure of spongistatin 1 |
| 07/25/1995 | US5436337 Anticarcinogenic agents |
| 07/25/1995 | US5436235 3-aryl-glycidic ester derivatives |
| 07/25/1995 | US5436234 Eurcyl, brassidyl and nervonyl derivatives |
| 07/25/1995 | US5436221 Oligopeptides as antitumor agents |
| 07/25/1995 | US5435990 Chelate-antibody complexes, treatment and diagnosis of cancer, tetraazacyclododecane compounds |
| 07/25/1995 | CA2140813A1 Use of flavolignans as adjuvants in tumor therapy |
| 07/25/1995 | CA1336432C N-imidazo[1,2-b]-pyridazinyl carbamates |
| 07/25/1995 | CA1336409C Tumor or cancer cell killing therapy and agents useful therefor |
| 07/25/1995 | CA1336398C Method for reducing side effects of cancer therapy |
| 07/25/1995 | CA1336397C Methyl cellulose pharmaceutical composition |
| 07/21/1995 | CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use |
| 07/20/1995 | WO1995019436A1 Mammalian monocyte chemoattractant protein receptors |
| 07/20/1995 | WO1995019434A1 Tissue-specific enhancer active in prostate |
| 07/20/1995 | WO1995019431A1 Zinc finger protein derivatives and methods therefor |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/20/1995 | WO1995019344A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/20/1995 | WO1995019177A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors |
| 07/20/1995 | WO1995016696A3 Modified oligonucleotides, method for producing them and use as active substances |
| 07/20/1995 | WO1995016693A3 4'-o-sulfonyl-anthracycline derivatives |
| 07/20/1995 | WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/20/1995 | DE19500723A1 New variable domains of antibody recognising cancer specific mucin |
| 07/20/1995 | CA2181444A1 Vanadate compounds for the treatment of proliferative disorders, metastases and drug resistant tumors |
| 07/20/1995 | CA2180746A1 Gem-disubstituted azacyclic tachykinin antagonists |
| 07/19/1995 | EP0663393A1 Novel 3-amino/hydroxy-4- 4-benzoylphenylcarboxylamino/oxy -azepanes and their homologies as protein kinase inhibitors |
| 07/19/1995 | EP0662976A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 07/19/1995 | EP0662960A1 Unsymmetrically substituted bis-naphthalimides |
| 07/19/1995 | EP0662958A1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers |
| 07/19/1995 | EP0662950A1 Benzenealkanoic acids for cardiovascular diseases |
| 07/19/1995 | EP0662839A1 Vaccines and antigenic conjugates |
| 07/19/1995 | EP0662834A1 Novel epoxide-containing compounds |
| 07/19/1995 | EP0662827A1 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/19/1995 | EP0646129A4 Receptor-type tyrosine kinase-like molecules. |
| 07/19/1995 | CN1105361A Methods for exhibiting angiogenisis and angiogenic diseases |
| 07/18/1995 | US5434287 Bifunctional DTPA-type ligand |
| 07/18/1995 | US5434185 Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts |
| 07/18/1995 | US5434176 Phenylimidazolidines |
| 07/18/1995 | US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 07/18/1995 | US5434172 Sulfonamide derivatives |
| 07/18/1995 | US5434160 Autoimmune diseases; prevention of excess cell proliferation or enzyme release |
| 07/18/1995 | US5434155 Quinoline derivative fumarates |
| 07/18/1995 | US5434146 Antitumor, breast cancer |
| 07/18/1995 | US5434131 Chimeric CTLA4 receptor and methods for its use |
| 07/18/1995 | US5433940 Synthetic molecules mimic action of hirudin by binding to both the low affinity anion-binding exosite and the catalytic site of thrombin |
| 07/18/1995 | CA2037596C Rebeccamycin analog by bromide precursor feeding |
| 07/18/1995 | CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them |
| 07/18/1995 | CA1336322C Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors |
| 07/13/1995 | WO1995018863A1 Composition containing nucleic acids, preparation and uses |
| 07/13/1995 | WO1995018854A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | WO1995018824A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/13/1995 | WO1995018815A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine |
| 07/13/1995 | WO1995018807A1 Novel 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agents |
| 07/13/1995 | WO1995018804A1 Water soluble onium salt of taxo-diterpenoid |
| 07/13/1995 | WO1995018803A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | WO1995018797A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 07/13/1995 | WO1995018622A1 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 07/13/1995 | WO1995018613A1 Self-assembled taxo-diperpenoid nanostructures |
| 07/13/1995 | WO1995018611A1 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl) alanine derivative as antitumor agent |
| 07/13/1995 | WO1995018610A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | WO1995018607A1 Pharmaceutical compositions |
| 07/13/1995 | WO1995018606A1 Curcumin, analogues of curcumin and novel uses thereof |
| 07/13/1995 | WO1995018545A1 Food products for preventing development of diseases and process for preparing same |
| 07/13/1995 | WO1995016695A3 3'-aziridino-anthracycline derivatives |
| 07/13/1995 | CA2180477A1 Curcumin, analogues of curcumin and novel uses thereof |
| 07/13/1995 | CA2180446A1 Pharmaceutical compositions |
| 07/13/1995 | CA2180360A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | CA2180358A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 07/13/1995 | CA2180123A1 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders |
| 07/13/1995 | CA2179913A1 Novel serine protease inhibitors: derivatives of isothiazolidin-3-one-1,1 dioxide and 3-oxo-1,2,5-thiadiazolidine-1,1-dioxide |
| 07/13/1995 | CA2157603A1 3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl) alanine derivative as antitumor agent |
| 07/13/1995 | CA2157602A1 Novel 3-(substituted methyl)-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives useful as antitumor agents |
| 07/13/1995 | CA2139391A1 Azepanes and homologs thereof |
| 07/12/1995 | EP0662473A1 2-Oxindole derivatives as tyrosine kinase inhibitors |
| 07/12/1995 | EP0662150A1 Maspin, a novel serpin with tumor suppressing activity |
| 07/12/1995 | EP0662137A1 Gene transcription and ionizing radiation: methods and compositions |